Let's Go PO: Moving Beyond IV Therapy for ESBL UTIs
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
Let's Go PO: Moving Beyond IV Therapy for ESBL UTIs
-
Narrated by:
-
By:
In this episode, DASON Clinical Pharmacist Liaison and Operations Director, Dr. Libby Dodds Ashley, chats with Drs. Alice Landayan and Timothy Gauthier from Miami about their publication entitled "Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infections." The article can be viewed here: https://pubmed.ncbi.nlm.nih.gov/42534101/
For more information about DASON, please visit: https://dason.medicine.duke.edu/
adbl_web_anon_alc_button_suppression_t1
No reviews yet